Clinical Trial Update: HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating darunavir/ritonavir plus etravirine in acutely HIV-infected patients was terminated; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Intelence (Etravirine)
• Norvir (ritonavir)
• PREZISTA (darunavir)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Acute HIV Infection, HIV Infections | Phase 4 | Status: TERMINATED | Results posted: 2017-10-17